Genmab A/S (OTCMKTS:GNMSF) Shares Cross Above 50-Day Moving Average – What’s Next?

Genmab A/S (OTCMKTS:GNMSF)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $207.25 and traded as high as $224.42. Genmab A/S shares last traded at $223.83, with a volume of 23 shares trading hands.

Genmab A/S Stock Performance

The company’s 50 day moving average is $207.25 and its 200 day moving average is $227.28. The firm has a market cap of $14.79 billion, a P/E ratio of 12.78 and a beta of 1.04.

Genmab A/S (OTCMKTS:GNMSF) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $5.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $5.24. Genmab A/S had a net margin of 36.30% and a return on equity of 19.75%.

About Genmab A/S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.